Evidence map›Paper›PMID 42867727›Full record

ReviewNatural products and bioprospecting2026

Cytochalasins are a fascinating class of natural compounds: advances in the chemistry, biological activities, mode of action, and structure-activity relationships of novel cytochalasins isolated in the last decade are described.

Antonio Evidente

Abstract readReview
In one paragraph

Review in Natural products and bioprospecting, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Antonio EvidenteInstitute of Biomolecular Chemistry, Italian National Research Council (CNR), Viale Campi Flegrei 34, 80078 Pozzuoli, Italy. evidente@unina.it.ORCID http://orcid.org/0000-0001-9110-1656

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytochalasins are a very intriguing group of natural compounds. Since the first isolation of the well-known cytochalasins A and B in 1966, over 300 analogues have been described as metabolites, primarily produced by various fungal genera. Their bioactivities, targets, total syntheses, and biosyntheses had been also extensively investigated. After the review of Scherlach et al., 2010 several other cytochalasins, isolated from different fungal sources, their biological activities and potential applications, were extensively described. In particular, during the last decades (2014-2024), as deduced from SciFinder research 259 articles, excluding reviews, were published essentially on new cytochalasins from new fungal sources and their biological activity and their potential application were reported. The reviews published in the same time (2014-2024) treated essentially the biological activities, the mode of action, the biosynthesis of already known cytochalasins and frequently the description was also extended and compared to other classes of natural compounds. The aims of the present review is to cover this gap reporting about the structure and biological activities of new cytochalasins isolated in the last decade (2014-2024) by fungi, endophytic fungi, essentially cohabitants in plants, and marine organisms. Furthermore, a brief section describing the cytochalasins Produced by lichens is also included. For some cytochalasins, the results of structure-activity and on the mode of action studies and potential biotechnological application will be also described.

Indexed as

Chemical and biological characterizationCovering period 2014–2024CytochalaisinsSourceSructure activity relationships

Identifiers

PMID42867727
PMCPMC13661847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.